2010 Scrip 100 - Changes pharma can believe in?
This article was originally published in Scrip
Executive Summary
Ian Schofield picks some of the most significant developments in the health policy and regulation circles in the first half of 2010 and explains their likely impacts on pharma. Barack Obama signed into law US health reform legislation, price cut fever spread across European markets and Japan's Chuikyo is mulling reforms to the country's drug reimbursement pricing system.